Objective This study aimed to evaluate dyslipidemia in Ghanaian subjects with type 2
diabetes. Results Hundred individuals with type 2 diabetes and 61 apparently healthy …

Background Diabetes is a global health challenge with escalating prevalence rates.
Cardiovascular complications represent the leading cause of mortality among individuals …

Background: Dyslipidemia is a major risk factor for cardiovascular diseases, which in turn
contribute 68% of mortality among type 2 diabetics. The study aimed to determine …

Background Dyslipidemia is one of the major modifiable risk factors for cardiovascular
diseases (CVD) in a type-2 diabetic (T2DM) patient. Dyslipidemia in T2DM patients is …

Abstract Background and Objective: Lipid abnormalities are commonly found in persons with
diabetes mellitus but there is paucity of recent literature relating to local incidence. This …

Background Diabetes mellitus (DM) is a major health problem in Sudan and is a leading
cause of morbidity and mortality. Dyslipidemia is a major complication of diabetes and an …

Diabetes mellitus (DM) is a common endocrine metabolic disorder and a leading cause of
death worldwide. Dyslipidemia is a well-recognized manifestation of uncontrolled DM …

The association between dyslipidemia and diabetes mellitus is well established. Although
various lipoprotein abnormalities have been described in patients with diabetes mellitus …

Background and Objectives: Dyslipidaemia and its associated complications have been
reported to increase mortality among type 2 diabetes mellitus (T2DM) patients. However …

Background: Dyslipidemia has been noted to play an integral role in the pathogenesis and
progression of micro and macrovascular complications in diabetes mellitus patients. The …